Assessment of the Treatment and Economic Impact of Weekly vs. Monthly Erythropoiesis Stimulating Protein Therapy on Patients With CKD

Assessment of the Treatment and Economic Impact of Weekly vs. Monthly Erythropoiesis Stimulating Protein Therapy on Patients With CKD

Identification: nnj_ma07A1
Issue: March-April 2007
Volume: Vol. 34, No. 2

Standard: $30.00

Description

This article is available to members for free.

Goal: To illustrate the differences in the economic burden caused by anemia treaments on CKD patients who are not yet on dialysis.

Objectives:

  1. Enumerate the economic impact on families and patients with chronic kidney disease not yet receiving dialysis cause by the treatment for anemia.
  2. Compare and contrast the economics of weekly versus monthly treatments found in a study of patients with CKD who are not yet on dialysis.
  3. Recommend a plan for easing economic burden for patients with CKD needing treatment for anemia.


Note: The research for this article was supported by a grant from Amgen, Inc. All authors that did not so indicate have reported that they have no actual or potential confilct of interest in relation to this continuing education article.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.